Jack A. Khattar, President, CEO: Supernus Pharmaceuticals SUPN Sell · Filed 03/16

Trade details

Type: Insider sale
Amount: $1,209,072.42
Shares · price: 24,138 sh · $50.09 a share
Held after: 968,962 sh
Stock: Supernus Pharmaceuticals SUPN
Person: Jack A. KhattarPresident, CEO
Trade date: 26/03/13
Filed: 26/03/16
Days to filing: 3 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Supernus Pharmaceuticals trades, last 26 weeks

What else happened in Supernus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/11~04/12

Jack A. Khattar's recent trades

Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$547.8K
10,742 sh
$547.8K
Filed 03/16
Traded 03/13
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$6,210
120 sh
$6,210
Filed 03/16
Traded 03/13
Jack A. KhattarDirector, Officer
Planned sale10b5-1 planSupernus Pharmaceuticals
Planned sale10b5-1 plan
Supernus Pharmaceuticals
SUPN
$1.8M
35,000 sh
$1.8M
Filed 03/13
Traded 03/13
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$3M
58,371 sh
$3M
Filed 25/10/10
Traded 25/10/09
Jack A. KhattarPresident, CEO
Sell10b5-1 planSupernus Pharmaceuticals
Sell10b5-1 plan
Supernus Pharmaceuticals
SUPN
$78.7K
1,529 sh
$78.7K
Filed 25/10/10
Traded 25/10/09

Jack A. Khattar, CEO — sold $1.2M of Supernus Pharmaceuticals SUPN · 2.4% of holdings · 10b5-1 plan | Whalegun